Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Moodys
McKesson
Dow
AstraZeneca

Last Updated: March 27, 2023

Pharmaderm Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for PHARMADERM, and what generic and branded alternatives to PHARMADERM drugs are available?

PHARMADERM has twenty-six approved drugs.



Summary for Pharmaderm
US Patents:0
Tradenames:14
Ingredients:13
NDAs:26

Drugs and US Patents for Pharmaderm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm NYSTATIN TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide CREAM;TOPICAL 062596-001 Oct 8, 1985 DISCN No No See Plans and Pricing See Plans and Pricing
Pharmaderm GENTAMICIN SULFATE gentamicin sulfate OINTMENT;TOPICAL 062534-001 Oct 10, 1984 DISCN No No See Plans and Pricing See Plans and Pricing
Pharmaderm BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 019140-001 Sep 4, 1984 DISCN No No See Plans and Pricing See Plans and Pricing
Pharmaderm HYDROCORTISONE hydrocortisone OINTMENT;TOPICAL 088842-001 Feb 9, 1987 DISCN No No See Plans and Pricing See Plans and Pricing
Pharmaderm BACITRACIN-NEOMYCIN-POLYMYXIN bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 062167-001 Approved Prior to Jan 1, 1982 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Harvard Business School
Colorcon
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.